Effect of Liraglutide on Cardiovascular Function and Myocardial Tissue Characteristics in Type 2 Diabetes Patients of South Asian Descent Living in the Netherlands: A Double‐Blind, Randomized, Placebo‐Controlled Trial

BACKGROUND: The glucagon‐like peptide‐1 (GLP‐1) receptor agonist liraglutide may be beneficial in the regression of diabetic cardiomyopathy. South Asian ethnic groups in particular are at risk of developing type 2 diabetes. PURPOSE: To assess the effects of liraglutide on left ventricular (LV) diast...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Magn Reson Imaging
Main Authors: Paiman, Elisabeth H.M., van Eyk, Huub J., van Aalst, Minke M.A., Bizino, Maurice B., van der Geest, Rob J., Westenberg, Jos J.M., Geelhoed‐Duijvestijn, Petronella H., Kharagjitsingh, Aan V., Rensen, Patrick C.N., Smit, Johannes W.A., Jazet, Ingrid M., Lamb, Hildo J.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2019
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7318583/
https://ncbi.nlm.nih.gov/pubmed/31799782
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jmri.27009
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados